Skip to main content

H34.8120 vs H34.8190

H34.8120 (Central retinal vein occlusion, left eye, with macular edema) compared with H34.8190 (Central retinal vein occlusion, unspecified eye, with macular edema), from the official CMS tabular data. H34.8120 and H34.8190 code the same condition on opposite sides. MedCoder-derived

Relationship

Review

Laterality relationship

H34.8120
Left
Central retinal vein occlusion, left eye, with macular edema
H34.8190
Unspecified
Central retinal vein occlusion, unspecified eye, with macular edema

Same condition; these differ only in which side is documented.

These codes share a category and title and differ only in the side affected. The documentation decides which applies, and a bilateral code is reported only where the code set provides one.

Source: ICD-10-CM tabular list (laterality variant derived from the code title)

Can these codes be reported together?

Same condition, opposite side. H34.8120 and H34.8190 name the same condition on opposite sides of the body.

Same category and title, differing only in which side is affected — the documentation decides which one applies, and a bilateral code is reported only where the code set provides one.

Side by side

H34.8120Central retinal vein occlusion, left eye, with macular edemaH34.8190Central retinal vein occlusion, unspecified eye, with macular edema
Billing statusBillableBillable
ClassificationH00-H59 — Diseases of the eye and adnexaH00-H59 — Diseases of the eye and adnexa
DefinitionCentral retinal vein occlusion, left eye, with macular edema is a billable ICD-10-CM diagnosis code (H34.8120).Central retinal vein occlusion, unspecified eye, with macular edema is a billable ICD-10-CM diagnosis code (H34.8190).
7th characterOne of the following 7th characters is to be assigned to codes in subcategory H34.81 to designate the severity of the occlusion:One of the following 7th characters is to be assigned to codes in subcategory H34.81 to designate the severity of the occlusion:

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources